APA (7th ed.) Citation

Araki, E., Kawamori, R., Inagaki, N., Watada, H., Hayashi, N., Horie, Y., . . . Woerle, H. (2013). Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes, Obesity & Metabolism, 15(4), 364. https://doi.org/10.1111/dom.12039

Chicago Style (17th ed.) Citation

Araki, E., et al. "Long-term Safety of Linagliptin Monotherapy in Japanese Patients with Type 2 Diabetes." Diabetes, Obesity & Metabolism 15, no. 4 (2013): 364. https://doi.org/10.1111/dom.12039.

MLA (9th ed.) Citation

Araki, E., et al. "Long-term Safety of Linagliptin Monotherapy in Japanese Patients with Type 2 Diabetes." Diabetes, Obesity & Metabolism, vol. 15, no. 4, 2013, p. 364, https://doi.org/10.1111/dom.12039.